These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 20972517)

  • 1. The grapefruit: an old wine in a new glass? Metabolic and cardiovascular perspectives.
    Owira PM; Ojewole JA
    Cardiovasc J Afr; 2010; 21(5):280-5. PubMed ID: 20972517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bergamottin, lime juice, and red wine as inhibitors of cytochrome P450 3A4 activity: comparison with grapefruit juice.
    Bailey DG; Dresser GK; Bend JR
    Clin Pharmacol Ther; 2003 Jun; 73(6):529-37. PubMed ID: 12811362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Grapefruit and drug interactions.
    Prescrire Int; 2012 Dec; 21(133):294-5, 297-8. PubMed ID: 23373097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal drug transporter expression and the impact of grapefruit juice in humans.
    Glaeser H; Bailey DG; Dresser GK; Gregor JC; Schwarz UI; McGrath JS; Jolicoeur E; Lee W; Leake BF; Tirona RG; Kim RB
    Clin Pharmacol Ther; 2007 Mar; 81(3):362-70. PubMed ID: 17215845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interactions between grapefruit juice and cardiovascular drugs.
    Bailey DG; Dresser GK
    Am J Cardiovasc Drugs; 2004; 4(5):281-97. PubMed ID: 15449971
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 6'7'-Dihydroxybergamottin contributes to the grapefruit juice effect.
    Kakar SM; Paine MF; Stewart PW; Watkins PB
    Clin Pharmacol Ther; 2004 Jun; 75(6):569-79. PubMed ID: 15179411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicinal importance of grapefruit juice and its interaction with various drugs.
    Kiani J; Imam SZ
    Nutr J; 2007 Oct; 6():33. PubMed ID: 17971226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 6',7'-Dihydroxybergamottin in grapefruit juice and Seville orange juice: effects on cyclosporine disposition, enterocyte CYP3A4, and P-glycoprotein.
    Edwards DJ; Fitzsimmons ME; Schuetz EG; Yasuda K; Ducharme MP; Warbasse LH; Woster PM; Schuetz JD; Watkins P
    Clin Pharmacol Ther; 1999 Mar; 65(3):237-44. PubMed ID: 10096255
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Grapefruit juice increases felodipine oral availability in humans by decreasing intestinal CYP3A protein expression.
    Lown KS; Bailey DG; Fontana RJ; Janardan SK; Adair CH; Fortlage LA; Brown MB; Guo W; Watkins PB
    J Clin Invest; 1997 May; 99(10):2545-53. PubMed ID: 9153299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Grapefruit juice and drugs: a hazardous combination?].
    Lohezic-Le Devehat F; Marigny K; Doucet M; Javaudin L
    Therapie; 2002; 57(5):432-45. PubMed ID: 12611197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exposure-dependent inhibition of intestinal and hepatic CYP3A4 in vivo by grapefruit juice.
    Veronese ML; Gillen LP; Burke JP; Dorval EP; Hauck WW; Pequignot E; Waldman SA; Greenberg HE
    J Clin Pharmacol; 2003 Aug; 43(8):831-9. PubMed ID: 12953340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re: The grapefruit: an old wine in a new glass? Metabolic and cardiovascular perspectives.
    Muller FO
    Cardiovasc J Afr; 2011; 22(1):37. PubMed ID: 21298205
    [No Abstract]   [Full Text] [Related]  

  • 13. Processing grapefruit juice with γ-cyclodextrin attenuates its inhibitory effect on cytochrome P450 3A activity.
    Yamasaki K; Iohara D; Oyama Y; Nishizaki N; Kawazu S; Nishi K; Kadowaki D; Taguchi K; Otagiri M; Seo H
    J Pharm Pharmacol; 2020 Mar; 72(3):356-363. PubMed ID: 31828807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Grapefruit juice-drug interactions: Grapefruit juice and its components inhibit P-glycoprotein (ABCB1) mediated transport of talinolol in Caco-2 cells.
    de Castro WV; Mertens-Talcott S; Derendorf H; Butterweck V
    J Pharm Sci; 2007 Oct; 96(10):2808-17. PubMed ID: 17542018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Grapefruit-drug interactions.
    Seden K; Dickinson L; Khoo S; Back D
    Drugs; 2010 Dec; 70(18):2373-407. PubMed ID: 21142260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Food-drug interactions: grapefruit juice.
    Diaconu CH; Cuciureanu M; Vlase L; Cuciureanu R
    Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):245-50. PubMed ID: 21682192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug interaction potentials among different brands of grapefruit juice.
    Uesawa Y; Mohri K
    Pharmazie; 2008 Feb; 63(2):144-6. PubMed ID: 18380401
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of grapefruit juice on intestinal P-glycoprotein: evaluation using digoxin in humans.
    Parker RB; Yates CR; Soberman JE; Laizure SC
    Pharmacotherapy; 2003 Aug; 23(8):979-87. PubMed ID: 12921244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Grapefruit juice-drug interactions. 1998.
    Bailey DG; Malcolm J; Arnold O; Spence JD
    Br J Clin Pharmacol; 2004 Dec; 58(7):S831-40; discussion S841-3. PubMed ID: 15595979
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug interactions with grapefruit juice.
    Ameer B; Weintraub RA
    Clin Pharmacokinet; 1997 Aug; 33(2):103-21. PubMed ID: 9260034
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.